elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35057308-72781ACE-5F4B-408E-89D0-58FDDFA77668
Q35057308-72781ACE-5F4B-408E-89D0-58FDDFA77668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-72781ACE-5F4B-408E-89D0-58FDDFA77668
Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.
P932
Q35057308-72781ACE-5F4B-408E-89D0-58FDDFA77668
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35057308-72781ACE-5F4B-408E-89D0-58FDDFA77668
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bce5dc612662230df898e32596f48e3b65d2801e
P932
4319629
http://www.w3.org/2001/XMLSchema#string